Reuters logo
2 个月前
BRIEF-Prometic Life Sciences Inc plasminogen administration shown to reduce acute lung injury
2017年5月8日 / 上午11点22分 / 2 个月前

BRIEF-Prometic Life Sciences Inc plasminogen administration shown to reduce acute lung injury

1 分钟阅读

May 8 (Reuters) - Prometic Life Sciences Inc:

* Prometic Life Sciences Inc - plasminogen administration shown to reduce acute lung injury ("ali") in an acute pancreatitis model

* Prometic Life Sciences Inc - PBI-4050 is safe and well tolerated and shows evidence of benefit in idiopathic pulmonary fibrosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below